Identification of incident CKD stage 3 in research studies

American Journal of Kidney Diseases

Volumn 64, Issue 2, 2014, Pages 214-221

  Grams, Morgan E ^a   Rebholz, Casey M ^b   McMahon, Blaithin ^a   Whelton, Seamus ^a   Ballew, Shoshana H ^b   Selvin, Elizabeth ^b   Wruck, Lisa ^c   Coresh, Josef ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c IL   (United States)

Author keywords

administrative data; Chronic kidney disease (CKD); CKD surveillance; diagnostic codes; identification; incident; Index Words; loss to follow up; screening; validation

Indexed keywords

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; COMORBIDITY; DIAGNOSTIC ACCURACY; DISEASE SURVEILLANCE; FEMALE; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTIVE VALUE; STAGING; UNITED STATES;

ADMINISTRATIVE DATA; CHRONIC KIDNEY DISEASE (CKD); CKD SURVEILLANCE; DIAGNOSTIC CODES; IDENTIFICATION; INCIDENT; LOSS TO FOLLOW-UP; SCREENING; VALIDATION;

AGED; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HOSPITALIZATION; HUMANS; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC;

EID: 84905115537     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2014.02.021     Document Type: Article

References (30)

1. B.C. Astor, K. Matsushita, and R.T. Gansevoort et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts Kidney Int 79 12 2011 1331 1340
2. R.T. Gansevoort, K. Matsushita, and M. van der Velde et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts Kidney Int 80 1 2011 93 104
3. K.S. Kinchen, J. Sadler, and N. Fink et al. The timing of specialist evaluation in chronic kidney disease and mortality Ann Intern Med 137 6 2002 479 486
4. A.V. Kshirsagar, H. Bang, and A.S. Bomback et al. A simple algorithm to predict incident kidney disease Arch Intern Med 168 22 2008 2466 2473
5. L.D. Bash, J. Coresh, and A. Kottgen et al. Defining incident chronic kidney disease in the research setting: the ARIC Study Am J Epidemiol 170 4 2009 414 424
6. M.G. Shlipak, and E.C. Day Biomarkers for incident CKD: a new framework for interpreting the literature Nat Rev Nephrol 9 8 2013 478 483
7. K.J. Rothman, S. Greenland, and T.L. Lash Modern Epidemiology 3rd ed. 2008 Lippincott, Williams & Wilkins Philadelphia, PA
8. M. Szklo, and F.J. Nieto Epidemiology: Beyond the Basics 2nd ed. 2007 Jones & Bartlett Publishers Sudbury, MA
9. N.J. Law, J.M. Taylor, and H. Sandler The joint modeling of a longitudinal disease progression marker and the failure time process in the presence of cure Biostatistics 3 4 2002 547 563
10. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. THE ARIC Investigators Am J Epidemiol 129 4 1989 687 702
11. P. Muntner, J. He, B.C. Astor, A.R. Folsom, and J. Coresh Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the Atherosclerosis Risk in Communities Study J Am Soc Nephrol 16 2 2005 529 538
12. M.G. Shlipak, M.J. Sarnak, and R. Katz et al. Cystatin C and the risk of death and cardiovascular events among elderly persons N Engl J Med 352 20 2005 2049 2060
13. J.J. Scialla, H. Xie, and M. Rahman et al. Fibroblast growth factor-23 and cardiovascular events in CKD J Am Soc Nephrol 25 2 2014 349 360
14. C.A. Peralta, R. Katz, and M.J. Sarnak et al. Cystatin C identifies chronic kidney disease patients at higher risk for complications J Am Soc Nephrol 22 1 2011 147 155
15. J. Coresh, B.C. Astor, and G. McQuillan et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate Am J Kidney Dis 39 5 2002 920 929
16. J.H. Eckfeldt, L.E. Chambless, and Y.L. Shen Short-term, within-person variability in clinical chemistry test results. Experience from the Atherosclerosis Risk in Communities Study Arch Pathol Lab Med 118 5 1994 496 500
17. A.S. Levey, L.A. Stevens, and C.H. Schmid et al. A new equation to estimate glomerular filtration rate Ann Intern Med 150 9 2009 604 612
18. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease Kidney Int Suppl 3 2013 1 150
19. G. Zou A modified Poisson regression approach to prospective studies with binary data Am J Epidemiol 159 7 2004 702 706
20. Grams ME, Waikar SS, McMahon B, Whelton S, Ballew SH, Coresh J. Performance and limitations of administrative data in the identification of acute kidney injury [published online ahead of print January 23, 2014]. Clin J Am Soc Nephrol. http://dx.doi.org/10.2215/CJN.07650713.
21. M.E. Grams, E.K. Chow, D.L. Segev, and J. Coresh Lifetime incidence of CKD stages 3-5 in the United States Am J Kidney Dis 62 2 2013 245 252
22. N. Drey, P. Roderick, M. Mullee, and M. Rogerson A population-based study of the incidence and outcomes of diagnosed chronic kidney disease Am J Kidney Dis 42 4 2003 677 684
23. K.M. Narayan, J.P. Boyle, T.J. Thompson, S.W. Sorensen, and D.F. Williamson Lifetime risk for diabetes mellitus in the United States JAMA 290 14 2003 1884 1890
24. S.S. Waikar, R. Wald, and G.M. Chertow et al. Validity of International Classification of Diseases, Ninth Revision, Clinical Modification codes for acute renal failure J Am Soc Nephrol 17 6 2006 1688 1694
25. D.F. Ransohoff, and A.R. Feinstein Problems of spectrum and bias in evaluating the efficacy of diagnostic tests N Engl J Med 299 17 1978 926 930
26. M.E. Grams, L.C. Plantinga, and E. Hedgeman et al. Validation of CKD and related conditions in existing data sets: a systematic review Am J Kidney Dis 57 1 2011 44 54
27. M.E. Vlasschaert, S.A. Bejaimal, and D.G. Hackam et al. Validity of administrative database coding for kidney disease: a systematic review Am J Kidney Dis 57 1 2011 29 43
28. L.A. Stevens, G. Fares, and J. Fleming et al. Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease J Am Soc Nephrol 16 8 2005 2439 2448
29. M. Ferris, D.A. Shoham, M. Pierre-Louis, L. Mandhelker, R.K. Detwiler, and A.V. Kshirsagar High prevalence of unlabeled chronic kidney disease among inpatients at a tertiary-care hospital Am J Med Sci 337 2 2009 93 97
30. P.E. Ronksley, M. Tonelli, and H. Quan et al. Validating a case definition for chronic kidney disease using administrative data Nephrol Dial Transplant 27 5 2012 1826 1831